# Progress Note 05 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Arthur Ashe (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML013-SYN-TD
- Date: 1989-08-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Vivian Tolliver, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Periodic adult preventive visit; no new concerns. **S**

## History of present illness

Mr. Ashe is a 46-year-old man with HIV, diagnosed eleven months ago with cerebral toxoplasmosis and now well controlled on bictegravir, emtricitabine, and tenofovir alafenamide, and with coronary artery disease after two bypass operations, who comes for his yearly preventive visit five weeks after his six-month review. His viral load was not detected at three and six months, and his CD4 count was 262 last month. He takes every dose and knows to keep any antacid, calcium, or iron well apart from his HIV tablet; he has needed none. He has had no chest pain and has not needed nitroglycerin. He hits tennis balls three times a week and is back to full-time writing and coaching. His right hand has stayed strong. His weight has come back to where it was before his illness. Mood is good. He has told one more close friend about his diagnosis, on his own terms, and says that went well. He has no new concerns. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 46 |
| HIV | Viral load not detected at three and six months; CD4 262 last month |
| Heart | No angina; no nitroglycerin use; exercising three times a week |
| Medicines | Bictegravir, emtricitabine, and tenofovir alafenamide; trimethoprim-sulfamethoxazole; aspirin; atorvastatin; ezetimibe; nitroglycerin as needed, not used |
| Safety events | No emergency visits or hospital stays since discharge |
| Disclosure | His own choice; has told one more close friend |

## Health risk assessment

Completed by the patient on a tablet in a private room before the visit and reviewed with him by Dr. Tolliver; kept in the confidential part of the record. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good, and better than at any time since his diagnosis |
| Psychosocial | Supported by his family and a few close friends; some worry about who might learn of his diagnosis; no loneliness |
| Tobacco | Never used tobacco or e-cigarettes |
| Alcohol and drugs | AUDIT-C 1; no other drug use |
| Physical activity | Tennis drills three times a week and daily walking; about 200 minutes a week |
| Nutrition | Mediterranean-style diet; regular meals |
| Sleep | Seven hours a night |
| Sexual health | One long-term partner; understands that an undetectable viral load means HIV is not transmitted sexually |
| Activities of daily living | Independent |
| Home and road safety | Wears a seat belt; smoke detectors working; no firearms in the home |
| Hearing and vision | No concerns |
| Oral health | No dental visit in the past year |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight back to its usual level; no fever, night sweats, or fatigue |
| Eyes | Negative | No floaters, blurred vision, or eye pain |
| Ears, nose, mouth, and throat | Negative | No mouth sores, white patches, or swallowing trouble |
| Cardiovascular | Negative | No chest pain, palpitations, or ankle swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No abdominal pain, diarrhea, or blood in the stool |
| Genitourinary | Negative | No urinary symptoms, genital sores, or discharge |
| Musculoskeletal | Negative | No muscle aches on atorvastatin and ezetimibe; no joint pain |
| Integumentary | Negative | No rash or new skin lesions |
| Neurological | Negative | No headache, seizure, numbness, or weakness; right hand strong |
| Psychiatric | Negative | Mood good; PHQ-2 score 0; no thoughts of self-harm |
| Hematologic and lymphatic | Negative | No easy bruising or swollen glands |

12 systems reviewed. **S**

## Current medications

- Bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg, one tablet by mouth once daily; take two hours before or six hours after antacids, calcium, iron, or magnesium **S**
- Sulfamethoxazole 800 mg and trimethoprim 160 mg (double strength), one tablet by mouth twice daily **S**
- Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily **S**
- Atorvastatin 80 mg oral tablet, one tablet by mouth daily **S**
- Ezetimibe 10 mg oral tablet, one tablet by mouth daily **S**
- Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tablet **S**

## Allergies

- No known allergy **S**

## Objective

BP 118/72 mmHg; pulse 64 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 74.8 kg; BMI 21.9 kg/m². All vital signs are synthetic.

PHQ-2: 0; AUDIT-C: 1. All results are synthetic.

## Change since baseline

- AUDIT-C: 1 at baseline, 1 at this visit **S**

## Immunizations given today

- Recombinant zoster vaccine, dose 2 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well and relaxed; weight 74.8 kg, BMI 21.9 |
| Eyes | Conjunctivae clear; pupils equal and reactive |
| Mouth | No thrush, ulcers, or oral hairy leukoplakia; teeth and gums in fair repair |
| Neck and lymph nodes | No enlarged nodes in the neck, armpits, or groins |
| Chest wall | Healed sternotomy scar |
| Cardiovascular | Regular rhythm at 64 per minute; no murmur; no edema |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender; no liver or spleen enlargement |
| Skin | No rash or suspicious lesions |
| Neurological | Grip strength and fine finger movements equal on both sides; no focal deficit |
| Psychiatric | Euthymic; good insight |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the personalized prevention plan updated. Depression and alcohol screens negative. Colorectal cancer screening is due from age 45, and anal cancer screening is now recommended for him as a person with HIV aged 45 or older. **S**
   - Next preventive visit in one year.
2. **HIV infection** (B20). Viral load not detected and CD4 count rising; adherence excellent. **S**
   - Nine-month review in two months with viral load, CD4 count, blood count, and metabolic panel.
   - Syphilis test today, as recommended yearly for people with HIV.
3. **Coronary artery disease after two bypass operations** (I25.10). No angina; blood pressure 118/72; LDL 52 mg/dL four months ago. **S**
   - Continue aspirin, atorvastatin, and ezetimibe.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 118/72 mmHg |
| Cholesterol and statin therapy | Up to date | Secondary prevention: LDL 52 mg/dL on atorvastatin 80 mg and ezetimibe; lipoprotein(a) 24 mg/dL; yearly lipid panel next due in the winter |
| Diabetes screening | Up to date | HbA1c 5.4 percent at intake; recheck yearly on antiretroviral therapy |
| Healthy weight and activity | Completed today | BMI 21.9; weight back to its level before his illness. Integrase inhibitors can cause weight gain, so weight is tracked at every visit |
| Colorectal cancer screening | Ordered | Recommended from age 45; no prior screening. He chose colonoscopy, and a referral to gastroenterology was placed |
| Anal cancer screening | Due | Recommended for people with HIV from age 45; the options (anal cytology with or without HPV testing, then high-resolution anoscopy if abnormal) were explained, and he will decide at the nine-month visit |
| Prostate cancer screening | Not indicated | Shared decision-making about PSA testing begins at age 55 |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never used tobacco |
| Depression screening | Completed today | PHQ-2 score 0; PHQ-9 2 at the six-month review |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 1 |
| Syphilis screening | Ordered | Yearly for sexually active people with HIV; drawn today |
| Gonorrhea and chlamydia screening | Not indicated | One long-term partner and no symptoms; review yearly |
| Hepatitis C screening | Up to date | Antibody negative at diagnosis; repeat only if a risk arises |
| Tuberculosis screening | Up to date | Interferon-gamma release assay negative at diagnosis |
| Recombinant zoster vaccine | Completed today | Dose 2 given today, four months after dose 1; series complete |
| Hepatitis B vaccine | Up to date | Two-dose series complete; surface antibody 86 mIU/mL four months ago |
| Meningococcal ACWY vaccine | Up to date | Two-dose series complete; booster every five years |
| Pneumococcal vaccine | Up to date | PCV20 given at intake |
| Hepatitis A vaccine | Not indicated | Hepatitis A antibody positive at diagnosis; immune |
| Tetanus, diphtheria, and pertussis booster | Up to date | Tdap five years ago; next booster in five years |
| Influenza and COVID-19 vaccines, this season | Due | Both at the nine-month visit in the autumn |
| HPV vaccine | Not indicated | Not recommended after age 45 |
| Dental examination | Due | No dental visit in the past year; advised to book one, as recommended yearly for people with HIV |

## Advance care planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent, and a health care proxy form was completed; the agent is recorded in the confidential part of the chart and is not named here. He said that what matters most to him is staying active, his family, his work with young people, and keeping control of his own medical information. He chose not to record specific treatment preferences today. The plan will be revisited yearly or after any serious illness. **S**

## Guideline basis

- Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America (2020), HIV Medicine Association of the Infectious Diseases Society of America (Clinical Infectious Diseases)
- Adult Immunization Schedule by Medical Condition and Other Indication (2026), Centers for Disease Control and Prevention
- CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026), Aether Forge
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force

## Follow-up

- Nine-month HIV review in two months, with the influenza and COVID-19 vaccines and his decision about anal cancer screening. Colonoscopy through gastroenterology. Syphilis result by secure message. Next preventive visit in one year. **S**
- Next scheduled visit 1989-10-19: nine-month HIV review: decision to stop toxoplasmosis maintenance therapy. **S**
